295 related articles for article (PubMed ID: 25455993)
21. Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review.
Kim DJ; Yang WI; Choi SS; Kim KD; Chung KY
Chest; 2005 Mar; 127(3):755-61. PubMed ID: 15764754
[TBL] [Abstract][Full Text] [Related]
22. Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings.
Tomiyama N; Johkoh T; Mihara N; Honda O; Kozuka T; Koyama M; Hamada S; Okumura M; Ohta M; Eimoto T; Miyagawa M; Müller NL; Ikezoe J; Nakamura H
AJR Am J Roentgenol; 2002 Oct; 179(4):881-6. PubMed ID: 12239030
[TBL] [Abstract][Full Text] [Related]
23. Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems.
Ma Y; Li Q; Cui W; Miao N; Liu X; Zhang W; Zhang C; Wang J
Diagn Pathol; 2012 Sep; 7():120. PubMed ID: 22974165
[TBL] [Abstract][Full Text] [Related]
24. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients.
Okumura M; Ohta M; Tateyama H; Nakagawa K; Matsumura A; Maeda H; Tada H; Eimoto T; Matsuda H; Masaoka A
Cancer; 2002 Feb; 94(3):624-32. PubMed ID: 11857293
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors].
Ma YQ; Zhang C; Cui WL; Gulinaer A; Zhang W; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):820-4. PubMed ID: 22336207
[TBL] [Abstract][Full Text] [Related]
26. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.
Pfister F; Hussain H; Belharazem D; Busch S; Simon-Keller K; Becker D; Pfister E; Rieker R; Ströbel P; Marx A
Histopathology; 2017 Apr; 70(5):693-703. PubMed ID: 27791295
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathologic study of thymic epithelial tumors].
Adachi K; Hosaka N; Takao M; Fujinaga K
Kyobu Geka; 2005 Feb; 58(2):119-22. PubMed ID: 15724473
[TBL] [Abstract][Full Text] [Related]
28. [Expression of CD20 in thymomas and its clinical implication].
Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
[TBL] [Abstract][Full Text] [Related]
29. [Is the microscopic morphology of thymoma of clinical significance?].
Szołkowska M; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2005; 73(2):153-9. PubMed ID: 16756145
[TBL] [Abstract][Full Text] [Related]
30. Pathological aspects of malignant and benign thymic disorders.
Müller-Hermelink HK; Marx A
Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
[TBL] [Abstract][Full Text] [Related]
31. Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies.
Yang WI; Efird JT; Quintanilla-Martinez L; Choi N; Harris NL
Hum Pathol; 1996 Jan; 27(1):70-6. PubMed ID: 8543314
[TBL] [Abstract][Full Text] [Related]
32. World Health Organization histologic classification: an independent prognostic factor in resected thymomas.
Rena O; Papalia E; Maggi G; Oliaro A; Ruffini E; Filosso P; Mancuso M; Novero D; Casadio C
Lung Cancer; 2005 Oct; 50(1):59-66. PubMed ID: 16009453
[TBL] [Abstract][Full Text] [Related]
33. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.
Kim DJ; Yang WI; Kim SH; Park IK; Chung KY
Eur J Cardiothorac Surg; 2005 Oct; 28(4):611-6. PubMed ID: 16125946
[TBL] [Abstract][Full Text] [Related]
34. Interobserver variation in the classification of thymic tumours--a multicentre study using the WHO classification system.
Verghese ET; den Bakker MA; Campbell A; Hussein A; Nicholson AG; Rice A; Corrin B; Rassl D; Langman G; Monaghan H; Gosney J; Seet J; Kerr K; Suvarna SK; Burke M; Bishop P; Pomplun S; Willemsen S; Addis B
Histopathology; 2008 Aug; 53(2):218-23. PubMed ID: 18752504
[TBL] [Abstract][Full Text] [Related]
35. An institutional study on thymomas and thymic carcinomas: experience in 77 patients.
Rieker RJ; Muley T; Klein C; Schnabel PA; Herpel E; Meister M; Schirmacher P; Dienemann H; Pfannschmidt J
Thorac Cardiovasc Surg; 2008 Apr; 56(3):143-7. PubMed ID: 18365972
[TBL] [Abstract][Full Text] [Related]
36. Thymic epithelial tumors: a clinicopathologic study of 249 cases from a single institution.
Su XY; Wu WL; Liu N; Zhang SF; Li GD
Int J Clin Exp Pathol; 2014; 7(11):7760-7. PubMed ID: 25550813
[TBL] [Abstract][Full Text] [Related]
37. Pax8 expression in thymic epithelial neoplasms: an immunohistochemical analysis.
Weissferdt A; Moran CA
Am J Surg Pathol; 2011 Sep; 35(9):1305-10. PubMed ID: 21836478
[TBL] [Abstract][Full Text] [Related]
38. Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka.
Penzel R; Hoegel J; Schmitz W; Blaeker H; Morresi-Hauf A; Aulmann S; Hecker E; Mechtersheimer G; Otto HF; Rieker RJ
Int J Cancer; 2003 Jul; 105(4):494-8. PubMed ID: 12712440
[TBL] [Abstract][Full Text] [Related]
39. KI-67 antigen expression predicts survival and correlates with histologic subtype in the WHO classification of thymic epithelial tumors.
Comin CE; Messerini L; Novelli L; Boddi V; Dini S
Int J Surg Pathol; 2004 Oct; 12(4):395-400. PubMed ID: 15494865
[TBL] [Abstract][Full Text] [Related]
40. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.
Hayashi A; Fumon T; Miki Y; Sato H; Yoshino T; Takahashi K
J Clin Exp Hematop; 2013; 53(1):9-19. PubMed ID: 23801129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
